Travel Expense Reimbursement
If you have not already done so, please send all itemized receipts and submit to [email protected] . Please also read the entire Travel Expense Form (link below). Please be advised that we will not process meal claims during times when meals are available at the hotel as part of our event.
DEADLINE: All expenses must be submitted by October 19th, 2023 for reimbursement.
PARKING: For those who stayed overnight and drove to the hotel, your parking will be covered; however, if you live within the city of Toronto your parking costs will not be covered unless you need to drive for accessibility reasons. If you are not staying at the hotel and have driven from outside of Toronto, and are not able to take public transit, please be in touch to discuss whether we are able to cover parking for you during the day.
MEALS: This budget reflects meals consumed by an individual outside of meeting times (breakfast and lunch are provided during the two event days and are therefore not reimbursed). Please note that alcoholic beverages will not be reimbursed. These rates include taxes and gratuities. Itemized receipts must be attached, not credit card or debit slips alone, to receive reimbursement. These amounts have been updated based on the 2020 Provincial Government Travel, Meal and Hospitality Expenses Directive
Cabenuva Research Study
On behalf of a research group at St. Michael’s Hospital evaluating the early implementation of injectable long-acting cabotegravir/rilpivirine (CAB/RPV-LA) in Ontario.
This study aims to evaluate how CAB/RPV-LA may improve reach, effectiveness and maintenance of HIV treatment for marginalized individuals, and also its availability and implementation challenges for clinics in Ontario. Part of this study involves a survey of healthcare professionals (physician/nurse/pharmacist) designed to capture their experiences prescribing, coordinating, and/or administering injectable long-acting CAB/RPV-LA. The survey will take no more than 20 mins to complete and will ask questions about your clinic, the availability and delivery of CAB/RPV-LA at your clinic, and the barriers/facilitators at patient-, provider- and site-levels. All data is anonymously collected and no identifiable information is used.
The researchers aim to receive at least one response from each clinic. Kindly consider forwarding the survey (linked below) to a colleague whom you believe would be best suited to respond. Please be reminded that your institution may have policies for distribution of research invitations so please check with your local REB and/or institution before sharing.
Thank you very much for considering this request!